GERD Is Common Indication for Revisional Bariatric Surgery
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 1, 2023 -- For patients who have undergone bariatric surgery for gastroesophageal reflux disease (GERD), revision surgery is common and is mainly with a Roux-en-Y gastric bypass (RYGB), according to a study published online Oct. 31 in Surgical Endoscopy.
Sarah MacVicar, M.D., from the University of Alberta Hospital in Edmonton, Canada, and colleagues conducted a retrospective cohort study involving patients who required revisional surgery for GERD in 2020 using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program registry.
The researchers found that 4,412 patients required revisional surgery for GERD, representing 24 percent of all conversion procedures. Patients underwent sleeve gastrectomy as their original surgery in most cases (80.1 percent). For 84.4 percent of patients, the revisional surgery was RYGB. Overall, 11.9 percent of patients had major complications, and 0.23 percent of patients died within 30 days of revisional surgery. In 31 and 38 patients (0.70 and 0.86 percent), respectively, anastomotic leak and gastrointestinal bleeding were the major complications. Operative length, preoperative antacid use, and RYGB were predictors of major complications in multivariable analyses.
"Future studies should be directed towards better shared decision-making with patients to minimize the burden of GERD-associated bariatric revisional procedures," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Bariatric Surgery Tied to Higher Short-Term Risk for Venous Thromboembolism
THURSDAY, May 9, 2024 -- In the short term, bariatric surgery is associated with a greater risk for venous thromboembolism (VTE), but in the long-term, it is associated with lower...
Novel Score Validated for Diagnosis of Gastroesophageal Reflux Disease
MONDAY, May 6, 2024 -- A novel high-resolution manometry (HRM) score can stratify the risk and severity of gastroesophageal reflux disease (GERD), according to a study published...
Use of Acid-Suppression Therapy Linked to Migraine, Severe Headache
FRIDAY, April 26, 2024 -- Use of acid-suppression therapy is associated with higher odds of migraine or severe headache, according to a study published online April 24 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.